Feto-maternal outcome of pregnancy with thrombocytopenia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20241058Keywords:
Thrombocytopenia, Gestational thrombocytopenia in pregnancyAbstract
Background: Thrombocytopenia is the second most haematological abnormality in pregnancy where the platelets count below 1,50,000/µl. Gestational thrombocytopenia is most common cause of thrombocytopenia, accounts for 70% of thrombocytopenia in pregnancy.
Methods: It is retrospective study with 30 antenatal women at any gestational age having thrombocytopenia, platelet count less than 1,50,000/µl at SVP Hospital, Ahmedabad during duration of May 2023-November 2023. All the pregnant women who attend OPD and admitted in SVP Hospital, Ahmedabad were included in the study.
Results: The present study found that gestational thrombocytopenia (53.34%) accounted for most common cause of thrombocytopenia, followed by hypertensive disorders (10.0%), HELLP syndrome (6.67%), dengue and malaria (6.67%), DIC (6.67%) and ITP (3.34%) in which 53.34% women has mild, 36.67% has moderate and 10% has severe thrombocytopenia. In this study vaginal delivery accounts for 33.34% and caesarean delivery accounts for 66.67%. In present study 50.0% patient of gestational thrombocytopenia didn’t required any treatment. About 6.67% patients required transfusion of PRC and 33.34% of neonates needed NICU admission. Neonatal mortality due to complications like prematurity, septicemia was seen in 10.0% of the cases.
Conclusions: Outcome of pregnancy with moderate to severe thrombocytopenia depends mainly on the etiology of thrombocytopenia. Early interdisciplinary evaluation of thrombocytopenia during pregnancy can help in optimizing care as fetal outcomes and management depend on the etiology.
References
Williams obstetrics. American College of Obstetricians and Gynaecologists: Thrombocytopenia in pregnancy. 26th ed. Practice Bulletin No.207; 2019c.
KashyapR, Garg A, Pradhan M. Maternal and foetal outcomes of pregnancy in patients with immune thrombocytopenia. J Obstet Gynaecol India.2021;71(2):124130.
Maymon R, Strauss S, Vaknin Z, Weinraub Z, Herman A, Gayer G. Normal sonographic values of maternal spleen size throughout pregnancy. Ultra Medi Biol. 2006;32(12):1827-31.
Sharma JB. Textbook of obstetrics. Chapter: 35 American College of Obstetricians and Gynecologist (ACOG): Thrombocytopenia in pregnancy. 3rd ed. Practice Bulletin no. 207; 2019.
Kam PC, Thompson SA, Liew AC. Thrombocytopenia in the parturient. Anesthesia. 2004;59(3):255-64.
Dwivedi P, Puri M, Nigam A, Agarwal K. Fetomaternal outcome in pregnancy with severe thrombocytopenia. Euro Rev Medi Pharmacol Sci. 2012;16(11).
Fogerty AE. Thrombocytopenia in pregnancy: mechanisms and management. Transfus Med Rev. 2018;32(4):225-9.
Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, et al. Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol. 1990;162(3):163-68.
Singh J, Kumari K, Verma V. Study of thrombocytopenia in pregnancy: clinical presentation and outcome at tertiary care rural institute. Int J Repord Contracept Obstet Gynecol. 2020;9:1622-6.
Pandey A, Singh R. Thrombocytopenia in pregnancy: an institutional based prospective study of one year. Int J Res Med Sci. 2017;5(8):3502-05.
Sumathy V, Devi C, Padmanaban S. Prospective study of thrombocytopenia in pregnancy. Int J Clin Obstet Gynaecol. 2019;3(1):17-21.
Vyas R, Shah S, Yadav P, Patel U. Comparative study of mild versus moderate to severe thrombocytopenia in a tertiary care hospital. NHL J Med Sci. 2014;3(1).
Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, et al. Moderate to severe thrombocytopenia during pregnancy Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):163-8.
Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome assosciated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia- eclampsia. Am J Obstet Gynecol. 1986;155(3):501.
Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP(hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996;175(2):460-4.
